February JAAD: A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients
Feb 7, 2022
Episode Description
Anne Lynn Su Chang, MD interviewed by Vesna Petronic-Rosic, MD, FAAD
Proudly Supported by
